Xoma reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Agenus AGEN:US $ 0M 12.82M
Agios Pharmaceuticals AGIO:US $ 0.28M 0M
Ardelyx ARDX:US $ 0M 0M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Chimerix CMRX:US $ 0 0
Curis CRIS:US $ 0M 0M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Emergent Biosolutions EBS:US $ 801.5M 7.9M
Epizyme EPZM:US $ 232.49M 379K
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
Life Technologies LIFE:US $ 0M 0M
Macrogenics MGNX:US $ 0 0
Novartis NOVN:VX SF 24373M 150M
Novartis NVS:US $ 24373M 150M
Pfizer PFE:US $ 35656M 539M
Prothena PRTA:US 0 0
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M
Teva Pharmaceutical Industries TEVA:US $ 20840M 777M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 31.38M 0.25M